Find a Doctor

Benoit M. You

Université Claude Bernard Lyon 1
Male

Bio


Benoit You is in Lyon, France. They have been an author on 128 peer reviewed articles and participated in 11 clinical trials in the past 15 years.

Contact

Lyon, FR

Latest Advances


Latest Advance
Study
  • Condition: Germline BRCA-Mutated Metastatic Breast Cancer
  • Journal: The Lancet. Oncology
  • Treatment Used: Olaparib and Durvalumab
  • Number of Patients: 34
  • Published —
The purpose of the study was to assess the safety and activity of Olaparib in combination with Durvalumab in patients with germline BRCA1-mutated or BRCA1-mutated metastatic breast cancer.
Latest Advance
Study
  • Condition: Cancer with Mild to Moderate Hepatic Impairment
  • Journal: The Journal of pharmacology and experimental therapeutics
  • Treatment Used: Osimertinib
  • Number of Patients: 22
  • Published —
This study tested the safety and efficacy of using osimertinib to treat cancer patients with mild to moderate hepatic impairment.

Clinical Trials


Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 100
  • Start Date: January 1, 2021
Impact of Telemonitoring for the Management of Side Effects in Patients With Melanoma, Lung or Renal Cancer, Treated With Immunotherapy Combination of Nivolumab and Ipilimumab.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Procedure, Drug
  • Participants: 132
  • Start Date: November 30, 2019
Assessment of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 2000
  • Start Date: July 2019
A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 410
  • Start Date: December 4, 2018
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Genetic
  • Participants: 10000
  • Start Date: February 2013
Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer

All Publications
View All


Publication
Study
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Published —
Reply to J. R. Lurain et al.
Publication
Study
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Published —
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial.

Contact

Lyon, FR

Insurance

Contact them to find out if they accept your insurance plan.